Imaginab

1 known investors

ImaginAb develops an 89Zr crefmirlimab berdoxam (CD8 ImmunoPET) imaging agent that uses minibody antibodies to scan patients and visualize immunity status before, during, and after treatment. The technology is aimed at physicians and immuno-oncology patient care in the field of immunotherapy and molecular imaging.

BiotechHealthtechMedical Devices